B+
Bull case
20%
Probability
Target price
$205.00
Analysis reference price unavailable
Analysis 2026-07-30 · RankAlpha Sentiment Codex
UHS
Universal Health ServicesBNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Q2 operating trends were solid, with revenue growth in both acute and behavioral health, higher EBITDA, continued share repurchases, and a potential Talkspace strategic benefit. The stored pre-print Zacks estimates of $5.66 EPS and $4.52 billion revenue were below reported results.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -3.3.
What can break
FY26 adjusted EPS and EBITDA guidance was cut versus the original forecast. [#SEC-8K-2026-07-28]
Momentum
40
Value
71
Sentiment
63
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $180.00 · Bull $205.00 · Bear $145.00Analysis 2026-07-30; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-30 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $192.50
Why
Momentum40 · Δ7d -22.3
Value71 · Δ7d 0.0
Sentiment63 · Δ7d -3.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta -3.3.
Contradictions & invalidation
- • FY26 adjusted EPS and EBITDA guidance was cut versus the original forecast. [#SEC-8K-2026-07-28]
- • Florida Medicaid supplemental-payment benefits may not recur because CMS approval beyond September 30, 2025 was not yet included in guidance. [#SEC-8K-2026-07-28]
- • The FY26 adjusted EPS and EBITDA outlook was reduced, the quarter benefited from a roughly $100 million Florida Medicaid payment, operating cash flow declined to $845 million from $909 million year over year, and Medicaid reimbursement, uninsured volumes, litigation, financing, and Talkspace integration remain risks.
Catalyst clock
2026-07-27
July 27 Q2 release: strong reported results but FY26 profit outlook reduced
Lead driver: Sentiment · See AI snapshot
Momentum
40
9% active weight
Current posture
7d trendSoftening
Δ7d
-22.3
Δ21d
-22.9
Value
71
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-0.1
Sentiment
63
62% active weight
Current posture
7d trendSoftening
Δ7d
-3.3
Δ21d
-3.5
Why this grade
Composite grade B. Momentum 39.7 / Value 70.8 / Sentiment 63.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-30. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$180.00
Analysis reference price unavailable
Analysis 2026-07-30 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$145.00
Analysis reference price unavailable
Analysis 2026-07-30 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$10.05B
Beta
1.27
Shares Out
58.94M
P/E (TTM)
10.6
P/S (TTM)
0.82
P/FCF (TTM)
15.20
Rev YoY
+8.3%
EPS YoY
+10.1%
Gross Margin
+11.4%
Op Margin
+11.4%
Net Debt
$5.03B
Current Ratio
1.12
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data